North China Pharmaceutical Co., Ltd.

North China Pharmaceutical Co. has faced a notable decline in its stock price, reflecting broader market trends. The company has experienced significant decreases over various time frames, with financial metrics indicating challenges in growth and declining net sales. Its performance contrasts with the positive return of the China Shanghai Composite index.

North China Pharmaceutical Co., Ltd. saw a notable stock increase on March 9, 2026, achieving an intraday high amid a declining broader market. While the company has shown resilience recently, it faces longer-term performance challenges, reflected in its one-year and three-year declines. The firm maintains a significant market capitalization and a leveraged position.